PRN: Rosacea Drugs Price Analysis and Strategies 2012-2016 & Forecasts to 2021 - Research and Markets

21/feb/2017 17:12:27 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Rosacea Drugs Price Analysis and Strategies 2012-2016 & Forecasts to 2021 - Research and Markets

 
[21-February-2017]
 

DUBLIN, Feb. 21, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Rosacea Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Rosacea Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Rosacea market.

The research answers the following questions:

  • What are the key drugs marketed for Rosacea and their clinical attributes? How are they positioned in the Global Rosacea market?
  • What are the unit prices and annual treatment cost for Rosacea therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Rosacea drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Rosacea?

Research Scope:

  • Rosacea Treatment Options - Identify key drugs marketed and prescribed for Rosacea in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
  • Rosacea Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Rosacea
  • Market Positioning - Identify how drugs are clinically and commercially positioned in the global Rosacea market
  • Rosacea Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Rosacea in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
  • Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
  • Rosacea New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

This research will help executives

  • Identify clinical attributes of your competitor drugs
  • Find out how the marketed products for Rosacea are clinically and commercially positioned
  • Understand the price of your competitor drugs by countries
  • Use Rosacea drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
  • Find out the pricing and reimbursement landscape by countries
  • Identify the unmet need in global Rosacea market
  • Identify the effective pricing for a new drug

Key Topics Covered:

1. Rosacea Treatment Options

2. Rosacea Drugs Clinical Attributes

3. Rosacea Drugs Market Positioning

4. Rosacea Drugs Price Analysis

5. Rosacea Drugs Price Benchmarks

6. Drug Pricing & Reimbursement Landscape

7. Rosacea Drugs Price Forecast

8. Rosacea Market Unmet Needs

9. Rosacea New Drug Pricing 

For more information about this report visit http://www.researchandmarkets.com/research/n2qh28/rosacea_drugs

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl